Show Screener



HZNP $32.23

0.37 (1.2%)


HZNP Profile

MEMBERSHIP
--
SECTOR
Health Care
MARKET CAPITALIZATION

$6 Billion

Mid-Cap
Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the primary care segment. It markets medicines in the areas of orphan diseases, rheumatology and primary care. The majority of revenue is generated in the United States.

HZNP Earnings

EPS

0.10

P/E

0.00

Q2 Earnings for Apr, May & Jun

Wed, Aug 7, 2019

Since Earnings Report

HZNP +36.3%

Q3 Earnings for Jul, Aug & Sep

Wed, Nov 6, 2019

Since Earnings Report

HZNP +8.0%

HZNP Dividend

Dividend Yield

0.00%

Dividend Rate

$0.00

Ex-Dividend Date

--

Dividend Pay Date

--

Dividend Frequency

--

Dividend Payments

--

HZNP Charts

All Time High $39.49 Mon, Jul 20, 2015


HZNP Industry Competitors


DRUG MANUFACTURERS
Novartis AG
Astrazeneca
GlaxoSmithKline
Bausch Health Companies Inc. Common Stock
Elanco Animal Health
Catalent Inc
The Medicines Co
Dr. Reddy's Laboratories Ltd Common Stock
Canopy Growth Corporation Common Stock
Taro Pharmaceutical Industries Ltd



Symbol MC DY Price Day YTD
HZNP $6.04 0.00% $32.23 1.2% 61.7%
















Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy